Welcome to LookChem.com Sign In|Join Free

CAS

  • or

14289-31-7

Post Buying Request

14289-31-7 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

14289-31-7 Usage

Uses

(S)-Prilocaine is a local anesthetic of the amino amide type. Prilocaine is often used in dentistry. Prilocaine is also often combined with lidocaine as a preparation for dermal anesthesia (lidocaine/prilocaine or EMLA), for treatment of conditions like paresthesia.

Check Digit Verification of cas no

The CAS Registry Mumber 14289-31-7 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 1,4,2,8 and 9 respectively; the second part has 2 digits, 3 and 1 respectively.
Calculate Digit Verification of CAS Registry Number 14289-31:
(7*1)+(6*4)+(5*2)+(4*8)+(3*9)+(2*3)+(1*1)=107
107 % 10 = 7
So 14289-31-7 is a valid CAS Registry Number.
InChI:InChI=1/C13H20N2O/c1-4-9-14-11(3)13(16)15-12-8-6-5-7-10(12)2/h5-8,11,14H,4,9H2,1-3H3,(H,15,16)

14289-31-7Downstream Products

14289-31-7Relevant articles and documents

Kinetics of degradation of 4-imidazolidinone prodrug types obtained from reacting prilocaine with formaldehyde and acetaldehyde

Larsen, Susan Weng,Sidenius, Martin,Ankersen, Michael,Larsen, Claus

, p. 233 - 240 (2003)

The kinetics of decomposition of 4-imidazolidinone prodrug types obtained by reacting prilocaine (I) with formaldehyde and acetaldehyde has been studied in aqueous solution in the pH range 1-7.4 at 60 and 37°C, respectively. At pHA plot of the logarithm of the apparent first-order rate constants for hydrolysis of II against pH resulted in a sigmoidal-shaped pH-rate profile characteristic for the hydrolysis of many N-Mannich bases. A half-life at pH 7.4 (60°C) of 6.9h for compound II was calculated. Compared to II the 4-imidazolidinone derived from acetaldehyde (III) exhibited enhanced instability in aqueous buffer solutions. The decomposition was followed at 37°C monitoring the decrease in concentration of intact (III). At acidic pH the reactions displayed strict first-order kinetics and the disappearance of III was accompanied by a concomitant formation of I. At pH 7.4, the rate data also applied reasonably well to first-order kinetics despite the observation that small amounts of III was formed at pH 7.4 from a solution containing equimolar concentrations of acetaldehyde and prilocaine (10 -4M). In case of III, a bell-shaped pH-rate profile was obtained by plotting the logarithm of the pseudo-first-order rate constants against pH indicating the involvement of a kinetically significant intermediate in the reaction pathway and a change of the rate-limiting step in the overall reaction with pH. For the stability studies performed at pH 6.9 and 7.4 product analysis revealed that parallel to formation of (I) an unknown compound (X) emerged. Compared to III, compound X is hydrolysed to give I at a slower rate (t 50%=30h at 37°C). Based on LC-MS data it is suggested that (X) is an isomeric form of III, which may exist in four diastereomeric forms. Thus, at physiological pH an initial relatively fast regeneration of I from III is to be expected followed by a slower drug activation resulting from hydrolysis of the isomeric form of III.

Preparation method of prilocaine base

-

Paragraph 0017, (2016/10/31)

The invention discloses a preparation method of prilocaine base. The method comprises the following steps: directly condensing 2-chloropropionic acid (formula V) and o-toluidine (formula IV) in the presence of chlorinated 4-(4,6-dimethoxy-1,3,5-triazine-2-yl)-4-methylmorpholine to obtain N-(2-methyl phenyl)-2-chloride propionamide (formula III); reacting the N-(2-methyl phenyl)-2-chloride propionamide (formula III) with n-propylamine (formula II) in an acetone solvent in the presence of granular potassium carbonate to obtain a crude product of prilocaine base; and refining the prilocaine base to obtain medicine-grade prilocaine base (formula I). The method disclosed by the invention overcomes the shortcomings of the prior art and has the advantages of mild reaction conditions, no pollution, no equipment corrosion, good quality, high yield and convenient operation and is suitable for industrial production.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 14289-31-7